Replies to post #75252 on NanoViricides Inc. (NNVC)

[ZincFinger]

Things that sound very similar to those without background may be very different. From what I can see, it appears that Vecoy is using chemistry that Dr. Diwan (Theracour/NNVC) did not include in his patent claims because it was inherently toxic and he didn't see it as worth bothering to cover.

Let Vecoy do what it can with the "dregs" and leftovers. It won't be any competition for NNVC, IMHO. Dr Diwan was many years ahead of Vecoy and if there is any infringement it will be by Vecoy, not NNVC

But again, it appears that Vecoy is working with the "leftovers".

[Ubertino]

Vecoy has a scaffold made non-immunogenic by coating it with a polymer such as PEG. And the scaffold itself can be made using origami folding on a nucleic acid nanostructure, a silicon wafer or a polymer.

I do not see that from NNVC.

I see no conflict, infringement or patent problems between Vecoy and NNVC.

The common denominator between them is they both trap viruses in the circulation system before the virus penetrates the cell to duplicate.

Vecoy is raising money to further develop their tech and I see no trials in near term.

[Ovidius]

By the time Seymour moves ahead with NNVC there will no longer be a market for NNVC, mark this post.